China SXT Pharmaceuticals (SXTC) Competitors $1.82 +0.05 (+2.53%) As of 07/3/2025 01:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. THTX, BHST, KRRO, GNLX, HURA, ANIX, PLX, PROC, CRDL, and ATOSShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Theratechnologies (THTX), BioHarvest Sciences (BHST), Korro Bio (KRRO), Genelux (GNLX), TuHURA Biosciences (HURA), Anixa Biosciences (ANIX), Protalix BioTherapeutics (PLX), Procaps Group (PROC), Cardiol Therapeutics (CRDL), and Atossa Genetics (ATOS). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Its Competitors Theratechnologies BioHarvest Sciences Korro Bio Genelux TuHURA Biosciences Anixa Biosciences Protalix BioTherapeutics Procaps Group Cardiol Therapeutics Atossa Genetics China SXT Pharmaceuticals (NASDAQ:SXTC) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk. Do insiders and institutionals have more ownership in SXTC or THTX? 5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate SXTC or THTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Theratechnologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is SXTC or THTX more profitable? China SXT Pharmaceuticals has a net margin of 0.00% compared to Theratechnologies' net margin of -4.18%. Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Theratechnologies -4.18%N/A -0.37% Which has better earnings & valuation, SXTC or THTX? China SXT Pharmaceuticals has higher earnings, but lower revenue than Theratechnologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.93M109.72-$3.10MN/AN/ATheratechnologies$85.87M1.68-$8.31M-$0.08-39.13 Which has more risk and volatility, SXTC or THTX? China SXT Pharmaceuticals has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Does the media prefer SXTC or THTX? In the previous week, Theratechnologies had 10 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 11 mentions for Theratechnologies and 1 mentions for China SXT Pharmaceuticals. Theratechnologies' average media sentiment score of 0.13 beat China SXT Pharmaceuticals' score of 0.00 indicating that Theratechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment China SXT Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Theratechnologies 1 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryChina SXT Pharmaceuticals beats Theratechnologies on 7 of the 12 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$218.13M$2.43B$5.54B$9.05BDividend YieldN/A1.78%5.24%4.02%P/E RatioN/A8.9827.4320.23Price / Sales109.72682.84422.11118.64Price / CashN/A158.5936.8958.07Price / Book0.014.588.045.67Net Income-$3.10M$31.34M$3.18B$249.13M7 Day Performance6.10%3.25%2.89%3.28%1 Month Performance36.19%7.08%3.70%5.56%1 Year Performance-78.06%0.17%36.15%21.12% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.1463 of 5 stars$1.83+2.5%N/A-78.3%$218.13M$1.93M0.0090News CoverageTHTXTheratechnologiesN/A$2.46-2.8%N/A+131.9%$116.33M$85.87M-30.75140News CoverageUpcoming EarningsAnalyst DowngradeGap UpBHSTBioHarvest SciencesN/A$6.83-3.3%$13.67+100.1%N/A$115.98M$25.19M-13.66N/AKRROKorro Bio2.3782 of 5 stars$11.75-4.9%$102.43+771.7%-66.3%$115.97M$2.27M-1.2470GNLXGenelux1.7538 of 5 stars$2.77-6.7%$17.75+540.8%+55.2%$112.07M$10K-3.1510HURATuHURA Biosciences1.3001 of 5 stars$2.53-0.8%$12.67+400.7%N/A$111.39MN/A0.00N/AAnalyst RevisionGap UpHigh Trading VolumeANIXAnixa Biosciences2.6732 of 5 stars$3.49+3.3%$9.00+157.9%+47.6%$108.87M$210K-9.185PLXProtalix BioTherapeutics2.922 of 5 stars$1.35-3.6%$15.00+1,011.1%+48.6%$107.47M$59.76M-10.38200Gap UpPROCProcaps GroupN/A$0.95-40.3%N/A-62.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeCRDLCardiol Therapeutics2.0717 of 5 stars$1.28+3.2%$8.67+577.1%-21.0%$102.49MN/A-3.7620Positive NewsGap UpATOSAtossa Genetics1.481 of 5 stars$0.80+1.3%$6.17+670.8%-29.3%$102.04MN/A-3.818News Coverage Related Companies and Tools Related Companies Theratechnologies Alternatives BioHarvest Sciences Alternatives Korro Bio Alternatives Genelux Alternatives TuHURA Biosciences Alternatives Anixa Biosciences Alternatives Protalix BioTherapeutics Alternatives Procaps Group Alternatives Cardiol Therapeutics Alternatives Atossa Genetics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTC Stock Alerts